bevacizumab gamma (Lytenava®)
HSE100056
25043
bevacizumab gamma
Lytenava®
Outlook Therapeutics
03/07/2025
27/05/2024
Rapid Review Completed
30/07/2025
Rapid Review Commissioned
03/07/2025
Pricing and Reimbursement Application Complete
03/07/2025